Skin examination is a delicate process that calls for the utmost attention. To curtail the progression of cancer, early detection comprises an important phenomenon. It is necessary for individuals to conduct a head-to-toe self-examination, which enables the determination of cancerous spots on the body. In healthcare settings, the entire body ought to be examined to determine changes in the skin. Skin lesions on the body may serve as an indicator of melanoma, which comprises the most common skin cancer (Bollinger, 2016). Likewise, a healthcare professional on a regular basis should conduct skin examination. A duration of 3 years between the skin examinations provides the most efficient cancer assessment duration. Color variability in the skin may serve as a symptom of cancer in the body. [“Write my essay for me?” Get help here.]
Men and women above the age of 65 are more likely to develop skin cancer (Berg, 2001). Their risk-averseness increases significantly when they are exposed to UV radiation because of direct sunshine. At this age, many people have a higher cumulative sun exposure. Fair-skinned men and women of this age project a higher risk-averseness to Melanoma, which is the deadliest skin cancer. This is based on the comparison of persons with different skin complexions. Recommendations to the patients on sun exposure include the avoidance of direct sunlight (Berg, 2001). Patients should also consider putting on wide-brimmed hats. They should further employ the use of sun creams when they are in the glare of the sun. The creams should have a high sun protection factor (SPF). It is also necessary for patients to put on clothes made of cotton. The affected area, in the chemotherapy session, should be well covered. Patients ought to stay in enclosed areas between 11am and 3pm during the summer and on hot occasions. If this cannot be avoided, then they should rest in places with shades to pre-empt direct exposure to sunlight.
I would want to ask the patient whether he/she has had past experiences with cancer. This will serve the purpose of determining the patient’s risk averseness to cancer. I will further inquire whether they have had exposure to some skin cancer risk factors. For instance, an increased sun exposure in the past could greatly increase the patient’s possibility of developing Melanoma (Berg, 2001). I would further ask the patient whether he/she is from a family with a history of atypical moles or cancerous trends. Based on a differential diagnosis, I would recommend a surgical excision to remove the tumultuous part in the skin. If the patient is unable to undertake surgery, I would then recommend radiotherapy. The final diagnosis would be the administration of chemotherapy and drug treatment to mitigate the spread of the cancerous tumor. In discussing the diagnoses with the patient, I will inform them of the possibility of this process halting the cancer progression. I will further ensure that they are aware of the risks that they are exposed to with every intervention instituted to remedy the cancer. I will further make an inquiry on the inputs and opinions while regarding the treatment initiatives. This way, I would be able to address their fears on the diagnoses.[Need an essay writing service? Find help here.]
There are several differences between malignant and benign lesions. A benign lesion is not cancerous even though it results from abnormal cell growth. Alternatively, a malignant lesion is a cancerous growth in the body. While a malignant lesion can spread to other parts of the body, a benign lesion is contained in one region and is not able to affect the tissues that surround it (Bollinger, 2016). A malignant lesion is very dangerous while a benign lesion is not dangerous and can easily be controlled. Most common types of benign tumors include Adenomas, papillomas, Lipomas, Myomas and Meningiomas. The most common types of cancerous tumors include Sarcomas and Carcinomas. [Click Essay Writer to order your essay]
Berg, A. O. (2001). Screening for skin cancer: Recommendations and rationale. American Journal of Preventive Medicine, 20(3), 44-46.
Bollinger, T. (2016, April). Benign and Malignant Tumors: What is the Difference? from TTAC: